ConductScience.org, home

Paper13638009

Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid.

SUGIMURA T and 3 others. Arch Biochem Biophys, 1959. Cited by 158 papers, by iCite.

Cite this record

ConductScience Library. Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid. Papers, record 13638009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/13638009

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid.
PubMed
Journal
Arch Biochem Biophys
PubMed
Year
1959
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
158
iCite
Revised in PubMed
2019-06-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1SUGIMURA TT
2BIRNBAUM SMS M
3WINITZ MM
4GREENSTEIN JPJ P

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amino AcidsMajor topic
Amino Acids, EssentialMajor topic
DietMajor topic
Food, FormulatedMajor topic
NeoplasmsMajor topic
NitrogenMajor topic
WaterMajor topic

Source PubMed

Download CSV of topics

Cited by70

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 158 citations.

PMIDTitleJournalYearIn PapersSource
42957232
Complete Response Demonstrated by [11C]methionine-PET Imaging of a Patient With Squamous-cell Carcinoma of the Tongue Treated With Chemotherapy, Immunotherapy and Methionine Restriction Without Radiation or Surgery: A Potential New Low-toxicity Treatment Paradigm for a Recalcitrant Disease.
In Vivo2026https://conductscience.org/library/papers/42957232PubMed
42746398Direct comparison of serine restriction on the viability of normal and cancer cells demonstrates that methionine restriction is more cancer specific.Front Oncol2026https://conductscience.org/library/papers/42746398PubMed
42665384The Phosphatidylinositol 3-Kinase (PI3K) Inhibitor Inavolisib Has Breast-cancer Synergy Combined With Recombinant Methioninase But Not on Normal Cells.In Vivo2026https://conductscience.org/library/papers/42665384PubMed
42298579The nutrigenomic-epigenetic axis in cancer: from dietary bioactives to precision oncology.Nutr Metab (Lond)2026https://conductscience.org/library/papers/42298579PubMed
42078306The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal Fibroblasts.Cancer Diagn Progn2026https://conductscience.org/library/papers/42078306PubMed
41760327Ultra-low Concentrations of Cisplatinum Down to the IC10 in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo.In Vivo2026https://conductscience.org/library/papers/41760327PubMed
41760305Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse Model.In Vivo2026https://conductscience.org/library/papers/41760305PubMed
41710278Methionine restriction in cancer: a dietary insight for therapy.Front Nutr2026https://conductscience.org/library/papers/41710278PubMed
41550357Methionine restriction for cancer therapy: From preclinical studies to clinical trials.Cancer Pathog Ther2026https://conductscience.org/library/papers/41550357PubMed
41487927Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal Cells.Cancer Diagn Progn2026https://conductscience.org/library/papers/41487927PubMed
41354708Catabolic rewiring in cancer impacts dietary interventions.Commun Biol2025https://conductscience.org/library/papers/41354708PubMed
41244132High plasma histidine concentration predicts a favorable prognosis in patients with ampullary cancer.Am J Cancer Res2025https://conductscience.org/library/papers/41244132PubMed
41008516Carboxy-Methylation of the Catalytic Subunit of Protein Phosphatase 2A (PP2Ac) Integrates Methionine Availability with Methionine Addicted Cancer Cell Proliferation.Biomolecules2025https://conductscience.org/library/papers/41008516PubMed
40900890Eradication of Extensive Lymph-Node, Bone and Pleural Metastases of a Breast-Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant Methioninase.Cancer Diagn Progn2025https://conductscience.org/library/papers/40900890PubMed
40611418Recombinant Expression of L-methioninase from Brevibacterium linens and Evaluation of its Anticarcinogenic Properties against MiaPaCa-2 Cells.Protein Pept Lett2025https://conductscience.org/library/papers/40611418PubMed
40605016The role of B12 deficiency and methionine synthase in methionine-dependent cancer cells.Cancer Metab2025https://conductscience.org/library/papers/40605016PubMed
40430461Methionine Dependency and Restriction in Cancer: Exploring the Pathogenic Function and Therapeutic Potential.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40430461PubMed
40427696Targeting Methionine Metabolism Reveals AMPK-SAMTOR Signaling as a Therapeutic Vulnerability in Prostate Cancer.Biology (Basel)2025https://conductscience.org/library/papers/40427696PubMed
40141131Posttranslational Regulation of Mammalian Sulfur Amino Acid Metabolism.Int J Mol Sci2025https://conductscience.org/library/papers/40141131PubMed
39941872Targeting Methionine Addiction of Osteosarcoma with Methionine Restriction to Overcome Drug Resistance: A New Paradigm for a Recalcitrant Disease.Cancers (Basel)2025https://conductscience.org/library/papers/39941872PubMed

See all 70 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/13638009

GET https://conductscience.org/api/papers/v1/13638009/cited_by?page=2